Press Releases
 
Press Releases
  Date Title and Summary View
Aug 31, 2015
MADISON, Wis.--(BUSINESS WIRE)-- Exact Sciences Corp. (Nasdaq: EXAS) today announced that the company will participate in the Baird 2015 Healthcare Conference in September. Kevin Conroy, the company's chairman and chief executive, will make Exact's presentation at the conference in New York at 9:4...
Aug 26, 2015
MADISON, Wis.--(BUSINESS WIRE)-- Exact Sciences Corp. (NASDAQ: EXAS) today announced that the Centers for Medicare and Medicaid Services (CMS) Advisory Panel on Clinical Diagnostic Laboratory Tests voted unanimously to maintain Medicare's current crosswalk pricing ($492.72) for Cologuard. The 11-0 vote, ...
Aug 19, 2015
Cologuard® recognized as a leading innovation in the state MADISON, Wis.--(BUSINESS WIRE)-- Exact Sciences Corp. (NASDAQ: EXAS) today announced that Cologuard was awarded a Wisconsin Innovation Award (WIA) in the "Healthcare/Health IT" category at the second annual ceremony hel...
Jul 30, 2015
MADISON, Wis.--(BUSINESS WIRE)-- Exact Sciences Corp. (Nasdaq: EXAS) today announced that the company will participate in two investor conferences during August. Kevin Conroy, the company's chairman and chief executive, will make Exact's presentation at the 2015 Wedbush PacGrow Healthcare Conferen...
Jul 21, 2015
MADISON, Wis.--(BUSINESS WIRE)-- Exact Sciences Corporation (NASDAQ: EXAS) today announced that Jefferies LLC and Robert W. Baird & Co. Incorporated, the underwriters of the Company's previously announced public offering of 7,000,000 shares of common stock, are reoffering the shares to the public at an initial ...
Jul 20, 2015
MADISON, Wis.--(BUSINESS WIRE)-- Exact Sciences Corporation (NASDAQ: EXAS) today announced an agreement to sell 7,000,000 shares of its common stock to Jefferies LLC and Robert W. Baird & Co. Incorporated as underwriters in an underwritten public offering pursuant to an effective shelf registration statement file...
Jul 20, 2015
MADISON, Wis.--(BUSINESS WIRE)-- Exact Sciences Corp. (Nasdaq: EXAS) today announced its business and financial results for the second quarter of 2015, and showed continued strong performance with more than 21,000 completed Cologuard tests for the quarter, up more than 90 percent from the first quarter, which ...
Jul 16, 2015
MADISON, Wis.--(BUSINESS WIRE)-- Exact Sciences Corp. (Nasdaq: EXAS) today announced that the company will host webcasts and conference calls to discuss its second-quarter 2015 financial results and of its annual stockholders meeting. Second-Quarter 2015 Webcast & Conference Call Details ...
Jul 14, 2015
MADISON, Wis.--(BUSINESS WIRE)-- Exact Sciences Corp. (Nasdaq: EXAS) today announced that the company will host webcasts and conference calls to discuss its second-quarter 2015 financial results and of its annual stockholders meeting. Second-Quarter 2015 Webcast & Conference Call Details ...
Jun 25, 2015
MADISON, Wis.--(BUSINESS WIRE)-- Exact Sciences Corp. (Nasdaq: EXAS) today announced that it expects to end the second quarter of 2015 with approximately 21,000 completed Cologuard tests. More than 13,800 physicians ordered at least one Cologuard test since the October 2014 launch and the...
Page:
1
... NextLast
= add release to Briefcase